Synonymous Substitution Rates Predict HIV Disease Progression as a Result of Underlying Replication Dynamics
暂无分享,去创建一个
Sergei L. Kosakovsky Pond | Beth Shapiro | Alexei J. Drummond | Andrew Rambaut | Philippe Lemey | Oliver G. Pybus | Helena Barroso | Nuno Taveira | P. Lemey | O. Pybus | N. Taveira | A. Rambaut | A. Drummond | B. Shapiro | Sergei L Kosakovsky Pond | H. Barroso
[1] Hui Li,et al. Nef-Mediated Suppression of T Cell Activation Was Lost in a Lentiviral Lineage that Gave Rise to HIV-1 , 2006, Cell.
[2] Sergei L. Kosakovsky Pond,et al. Adaptation to Different Human Populations by HIV-1 Revealed by Codon-Based Analyses , 2006, PLoS Comput. Biol..
[3] Martin Meier-Schellersheim,et al. CD4 T Cell Depletion Is Linked Directly to Immune Activation in the Pathogenesis of HIV-1 and HIV-2 but Only Indirectly to the Viral Load1 , 2002, The Journal of Immunology.
[4] J. Margolick,et al. Influence of Random Genetic Drift on Human Immunodeficiency Virus Type 1 env Evolution During Chronic Infection , 2004, Genetics.
[5] B. Walker,et al. Fitness Cost of Escape Mutations in p24 Gag in Association with Control of Human Immunodeficiency Virus Type 1 , 2006, Journal of Virology.
[6] Hirohisa Kishino,et al. Estimating absolute rates of synonymous and nonsynonymous nucleotide substitution in order to characterize natural selection and date species divergences. , 2004, Molecular biology and evolution.
[7] O. Pybus,et al. Unifying the Epidemiological and Evolutionary Dynamics of Pathogens , 2004, Science.
[8] I Quinti,et al. Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children born to human immunodeficiency virus-infected mothers. , 1990, The Journal of infectious diseases.
[9] C Chappey,et al. First case of mother-to-infant HIV type 1 group O transmission and evolution of C2V3 sequences in the infected child. French HIV Pediatric Cohort Study Group. , 1998, AIDS research and human retroviruses.
[10] Becca Asquith,et al. Inefficient Cytotoxic T Lymphocyte–Mediated Killing of HIV-1–Infected Cells In Vivo , 2006, PLoS biology.
[11] J V Giorgi,et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. , 1999, The Journal of infectious diseases.
[12] James Theiler,et al. Advantage of rare HLA supertype in HIV disease progression , 2003, Nature Medicine.
[13] Martin Meier-Schellersheim,et al. Pathogenesis of HIV infection: what the virus spares is as important as what it destroys , 2006, Nature Medicine.
[14] D. Ho,et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome , 1994, Journal of virology.
[15] S. Ho,et al. Relaxed Phylogenetics and Dating with Confidence , 2006, PLoS biology.
[16] M P Dempsey,et al. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. , 1991, Science.
[17] D. Strick,et al. Comprehensive Epitope Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Responses Directed against the Entire Expressed HIV-1 Genome Demonstrate Broadly Directed Responses, but No Correlation to Viral Load , 2003, Journal of Virology.
[18] A Muñoz,et al. A longitudinal study of neutralizing antibodies and disease progression in HIV-1-infected subjects. , 1999, The Journal of infectious diseases.
[19] C. Bustamante,et al. A statistical characterization of consistent patterns of human immunodeficiency virus evolution within infected patients. , 2005, Molecular biology and evolution.
[20] Z. Yang,et al. Likelihood ratio tests for detecting positive selection and application to primate lysozyme evolution. , 1998, Molecular biology and evolution.
[21] S. Muse,et al. Site-to-site variation of synonymous substitution rates. , 2005, Molecular biology and evolution.
[22] J. Goedert,et al. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. , 1999, Science.
[23] S. Lawn,et al. Contribution of Immune Activation to the Pathogenesis and Transmission of Human Immunodeficiency Virus Type 1 Infection , 2001, Clinical Microbiology Reviews.
[24] R Blumenthal,et al. Quantitation of human immunodeficiency virus type 1 infection kinetics , 1993, Journal of virology.
[25] Lawrence Corey,et al. Comprehensive Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific Gamma Interferon-Secreting CD8+ T Cells in Primary HIV-1 Infection , 2003, Journal of Virology.
[26] I. Thior,et al. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. , 1994, Science.
[27] R. Nielsen,et al. Effect of recombination on the accuracy of the likelihood method for detecting positive selection at amino acid sites. , 2003, Genetics.
[28] Andrew Rambaut,et al. Estimating the rate of molecular evolution: incorporating non-contemporaneous sequences into maximum likelihood phylogenies , 2000, Bioinform..
[29] Todd M. Allen,et al. HIV evolution: CTL escape mutation and reversion after transmission , 2004, Nature Medicine.
[30] J L Sullivan,et al. Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. , 1995, The New England journal of medicine.
[31] É. Oksenhendler,et al. HIV-specific effector cytotoxic T lymphocytes and HIV-producing cells colocalize in white pulps and germinal centers from infected patients. , 2001, Blood.
[32] A Esteves,et al. Follow-up study of intrahost HIV type 2 variability reveals discontinuous evolution of C2V3 sequences. , 2001, AIDS research and human retroviruses.
[33] David Posada,et al. Recombination estimation under complex evolutionary models with the coalescent composite-likelihood method. , 2006, Molecular biology and evolution.
[34] Allen G. Rodrigo,et al. Immune-Mediated Positive Selection Drives Human Immunodeficiency Virus Type 1 Molecular Variation and Predicts Disease Duration , 2002, Journal of Virology.
[35] D. Finzi,et al. Defective Virus Drives Human Immunodeficiency Virus Infection, Persistence, and Pathogenesis , 2006, Clinical and Vaccine Immunology.
[36] Robert D Holt,et al. Linking Dynamical and Population Genetic Models of Persistent Viral Infection , 2003, The American Naturalist.
[37] O. Pybus,et al. Bayesian coalescent inference of past population dynamics from molecular sequences. , 2005, Molecular biology and evolution.
[38] R. Nielsen,et al. Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. , 1998, Genetics.
[39] Daniel J. Wilson,et al. Evolution of the Human Immunodeficiency Virus Envelope Gene Is Dominated by Purifying Selection , 2006, Genetics.
[40] Sergei L. Kosakovsky Pond,et al. Not so different after all: a comparison of methods for detecting amino acid sites under selection. , 2005, Molecular biology and evolution.
[41] Helena Barroso,et al. Phylogenetic demonstration of two cases of perinatal human immunodeficiency virus type 2 infection diagnosed in adulthood. , 2004, AIDS research and human retroviruses.
[42] Alexei J Drummond,et al. Estimating mutation parameters, population history and genealogy simultaneously from temporally spaced sequence data. , 2002, Genetics.
[43] David L. Robertson,et al. Comparative Study of Adaptive Molecular Evolution in Different Human Immunodeficiency Virus Groups and Subtypes , 2004, Journal of Virology.
[44] Simon D W Frost,et al. A simple hierarchical approach to modeling distributions of substitution rates. , 2005, Molecular biology and evolution.
[45] Philip J. R. Goulder,et al. HIV and SIV CTL escape: implications for vaccine design , 2004, Nature Reviews Immunology.
[46] D. Richman,et al. Rapid evolution of the neutralizing antibody response to HIV type 1 infection , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[47] P. Fearnhead,et al. A coalescent-based method for detecting and estimating recombination from gene sequences. , 2002, Genetics.
[48] B. Korber,et al. Human immunodeficiency virus type 1 genetic evolution in children with different rates of development of disease , 1997, Journal of virology.
[49] S. Coppens,et al. Intrapatient variability of HIV type 1 group O ANT70 during a 10-year follow-up. , 1999, AIDS research and human retroviruses.
[50] J. Margolick,et al. Consistent Viral Evolutionary Changes Associated with the Progression of Human Immunodeficiency Virus Type 1 Infection , 1999, Journal of Virology.
[51] J. S. Sullivan,et al. Genomic Structure of an Attenuated Quasi Species of HIV-1 from a Blood Transfusion Donor and Recipients , 1995, Science.
[52] Martin A. Nowak,et al. Causes of HIV diversity , 1995, Nature.
[53] Bette Korber,et al. HIV-1 Nef is preferentially recognized by CD8 T cells in primary HIV-1 infection despite a relatively high degree of genetic diversity , 2004, AIDS.
[54] J I Mullins,et al. Re: Follow-up study of intrahost HIV type 2 variability reveals discontinuous evolution of C2V3 sequences. , 2001, AIDS research and human retroviruses.
[55] J K Kelly. Replication rate and evolution in the human immunodeficiency virus. , 1996, Journal of theoretical biology.
[56] Thomas C. Quinn,et al. Neutralizing Antibodies Do Not Mediate Suppression of Human Immunodeficiency Virus Type 1 in Elite Suppressors or Selection of Plasma Virus Variants in Patients on Highly Active Antiretroviral Therapy , 2006, Journal of Virology.
[57] Sergei L. Kosakovsky Pond,et al. HyPhy: hypothesis testing using phylogenies , 2005, Bioinform..
[58] Jan Albert,et al. Evolution of human immunodeficiency virus type 2 coreceptor usage, autologous neutralization, envelope sequence and glycosylation. , 2005, The Journal of general virology.
[59] Rafael Sanjuán,et al. The distribution of fitness effects caused by single-nucleotide substitutions in an RNA virus. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[60] S. Frost,et al. Genetic drift and within-host metapopulation dynamics of HIV-1 infection , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[61] S. Ray,et al. Convergent evolution within the V3 loop domain of human immunodeficiency virus type 1 in association with disease progression , 1995, Journal of virology.
[62] H. Whittle,et al. Maternal plasma viral RNA levels determine marked differences in mother-to-child transmission rates of HIV-1 and HIV-2 in The Gambia. MRC/Gambia Government/University College London Medical School working group on mother-child transmission of HIV. , 2000, AIDS.
[63] S. Williamson,et al. Adaptation in the env gene of HIV-1 and evolutionary theories of disease progression. , 2003, Molecular biology and evolution.
[64] Guido Silvestri,et al. Turnover of lymphocytes and conceptual paradigms in HIV infection. , 2003, The Journal of clinical investigation.
[65] Yang Liu,et al. Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[66] Hanneke Schuitemaker,et al. In vitro replication capacity of HIV-2 variants from long-term aviremic individuals. , 2006, Virology.
[67] John L. Sullivan,et al. Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection , 1995 .